# Avedro raises $42M and opens new manufacturing facility in Burlington, Massachusetts

Avedro, an ophthalmic pharmaceutical and medical device company, secured $42 million in equity and debt financing and opened a new manufacturing facility in Burlington, Massachusetts.

- Type: Investment
- Announced: 2017-04-27
- Where: Burlington, Massachusetts, United States
- Value: $42.0M
- Starts operating: 27 Apr 2017
- Status: completed
- Products: ophthalmic pharmaceuticals, medical devices for corneal cross-linking
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Avedro](https://endata.com/companies/23881.md)
- [HealthQuest Capital](https://endata.com/companies/23883.md) (investor)
- [OrbiMed Advisors](https://endata.com/companies/23884.md) (investor)
- [InterWest Partners](https://endata.com/companies/23885.md) (investor)

## Sources

- [finsmes.com](https://www.finsmes.com/2017/04/avedro-raises-42m-in-funding.html), 2017-04-27: "The company also announced the opening of its new manufacturing facility in Burlington, Massachusetts, located near the company’s headquarters in Waltham."
- [massdevice.com](https://www.massdevice.com/avedro-raises-42m-opens-new-mass-based-manufacturing-facility/), 2017-04-27: "Avedro said today it raised $42 million in equity and debt financing and opened a new manufacturing facility in Burlington, Mass."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.